🇺🇸 FDA
Patent

US 6620781

Glycopeptide carboxy-saccharide derivatives

expired A61KA61K38/00A61K47/40

Quick answer

US patent 6620781 (Glycopeptide carboxy-saccharide derivatives) held by Theravance, Inc. expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K38/00, A61K47/40, A61K47/6951, A61K9/0014